Back
Madrigal Pharmaceuticals Vs. Corcept Therapeutics Industry Stock Comparison
Buy
64
MDGL
Madrigal Pharmaceuticals
Last Price:
347.27
Seasonality Move:
43.27%
Buy
78
CORT
Corcept Therapeutics
Last Price:
57.51
Seasonality Move:
2.29%
Buy
64
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $347.45. The Score for MDGL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $57.54. The Score for CORT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $347.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $57.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.87 | Buy |
| Relative Strength Index (14 RSI): | 69.34 | Buy |
| Chaikin Money Flow: | 400104 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (230.37 - 343.05) | Buy |
| Bollinger Bands (100): | (217.71 - 297.35) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.45 | Buy |
| Relative Strength Index (14 RSI): | 64.7 | Buy |
| Chaikin Money Flow: | 529493 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.23 - 56.35) | Buy |
| Bollinger Bands (100): | (33.06 - 49.28) | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 314.73 | Buy |
| 20-day SMA: | 306.96 | Buy |
| 50-day SMA: | 253.03 | Buy |
| 200-day SMA: | 249.08 | Buy |
| 8-day EMA: | 323.08 | Buy |
| 20-day EMA: | 303.29 | Buy |
| 50-day EMA: | 273.39 | Buy |
| 200-day EMA: | 247.37 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.94 | Buy |
| 20-day SMA: | 53.34 | Buy |
| 50-day SMA: | 48.23 | Buy |
| 200-day SMA: | 33.69 | Buy |
| 8-day EMA: | 55.47 | Buy |
| 20-day EMA: | 53.46 | Buy |
| 50-day EMA: | 48.61 | Buy |
| 200-day EMA: | 37.24 | Buy |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.10 per share, and an increase next year of $10.03 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Madrigal Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||